View in EDS

Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403.

Saved in:
Bibliographic Details
Title: Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403.
Authors: Goldberg SB; Yale School of Medicine, New Haven, CT., Redman MW; SWOG Statistical Center, Seattle, WA., Lilenbaum R; Yale School of Medicine, New Haven, CT., Politi K; Yale School of Medicine, New Haven, CT., Stinchcombe TE; Duke Cancer Center, Durham, NC., Horn L; Vanderbilt-Ingram Cancer Center, Nashville, TN., Chen EH; Kaiser Permanente Medical Group/NCORP, Bellflower CA., Mashru SH; Kaiser Permanente Medical Group/NCORP, Portland, OR., Gettinger SN; Yale School of Medicine, New Haven, CT., Melnick MA; Yale School of Medicine, New Haven, CT., Herbst RS; Yale School of Medicine, New Haven, CT., Baumgart MA; University of Rochester Medical Center, Rochester, NY., Miao J; SWOG Statistical Center, Seattle, WA., Moon J; SWOG Statistical Center, Seattle, WA., Kelly K; UC Davis Comprehensive Cancer Center, Sacramento, CA., Gandara DR; UC Davis Comprehensive Cancer Center, Sacramento, CA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Dec 01; Vol. 38 (34), pp. 4076-4085. Date of Electronic Publication: 2020 Oct 06.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.20.01149